- Home
- SWBI vs ATYR Comparison
SWBI vs ATYR Comparison
Compare SWBI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWBI
- ATYR
- Stock Information
- Founded
- SWBI 1852
- ATYR 2005
- Country
- SWBI United States
- ATYR United States
- Employees
- SWBI N/A
- ATYR N/A
- Industry
- SWBI Ordnance And Accessories
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWBI Industrials
- ATYR Health Care
- Exchange
- SWBI Nasdaq
- ATYR Nasdaq
- Market Cap
- SWBI 429.0M
- ATYR 451.3M
- IPO Year
- SWBI N/A
- ATYR 2015
- Fundamental
- Price
- SWBI $7.74
- ATYR $4.70
- Analyst Decision
- SWBI Buy
- ATYR Strong Buy
- Analyst Count
- SWBI 2
- ATYR 6
- Target Price
- SWBI $12.00
- ATYR $20.20
- AVG Volume (30 Days)
- SWBI 887.0K
- ATYR 5.9M
- Earning Date
- SWBI 09-04-2025
- ATYR 08-12-2025
- Dividend Yield
- SWBI 6.72%
- ATYR N/A
- EPS Growth
- SWBI N/A
- ATYR N/A
- EPS
- SWBI 0.30
- ATYR N/A
- Revenue
- SWBI $474,661,000.00
- ATYR N/A
- Revenue This Year
- SWBI N/A
- ATYR $551.06
- Revenue Next Year
- SWBI $9.23
- ATYR $1,874.58
- P/E Ratio
- SWBI $25.80
- ATYR N/A
- Revenue Growth
- SWBI N/A
- ATYR N/A
- 52 Week Low
- SWBI $7.74
- ATYR $1.67
- 52 Week High
- SWBI $16.53
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- SWBI 31.68
- ATYR 42.54
- Support Level
- SWBI $7.88
- ATYR $5.46
- Resistance Level
- SWBI $8.36
- ATYR $7.29
- Average True Range (ATR)
- SWBI 0.22
- ATYR 0.65
- MACD
- SWBI 0.00
- ATYR -0.16
- Stochastic Oscillator
- SWBI 1.32
- ATYR 8.32
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.